I. Inoshima

发表

Induction of CDK inhibitor p21 gene as a new therapeutic strategy against pulmonary fibrosis.

Nobuyuki Hara, K. Kuwano, T. Maeyama, 2004, American journal of physiology. Lung cellular and molecular physiology.

Upregulation of Fas-signalling molecules in lung epithelial cells from patients with idiopathic pulmonary fibrosis.

K. Kuwano, T. Maeyama, N. Hagimoto, 2001, The European respiratory journal.

Oxidative stress in lung epithelial cells from patients with idiopathic interstitial pneumonias

K. Kuwano, N. Nakashima, T. Maeyama, 2003, European Respiratory Journal.

References Subscriptions Permissions Email Alerts TGF-β1 as an Enhancer of Fas-Mediated

K. Kuwano, T. Maeyama, N. Hagimoto, 2013 .

MAP kinase activation and apoptosis in lung tissues from patients with idiopathic pulmonary fibrosis

Koichiro Yoshida, Nobuyuki Hara, Kentaro Watanabe, 2002, The Journal of pathology.

Mitochondria-Mediated Apoptosis of Lung Epithelial Cells in Idiopathic Interstitial Pneumonias

K. Kuwano, N. Nakashima, T. Maeyama, 2002, Laboratory Investigation.

Patients with MAC Lung Disease Have a Low Visceral Fat Area and Low Nutrient Intake

I. Inoshima, H. Kumazoe, H. Omori, 2015, Pulmonary medicine.

Impaired host defence against Mycobacterium avium in mice with chronic granulomatous disease

I. Inoshima, Y. Nakanishi, M. Fujita, 2010, Clinical and experimental immunology.

Two cases of pulmonary cryptococcosis, negative of serum cryptococcal antigen and difficult to differentiate lung cancer

I. Inoshima, Y. Nakanishi, M. Fujita, 2007 .

Anti-monocyte chemoattractant protein-1 gene therapy attenuates pulmonary fibrosis in mice.

A. Takeshita, K. Kuwano, T. Maeyama, 2004, American journal of physiology. Lung cellular and molecular physiology.

Increased circulating levels of soluble Fas ligand are correlated with disease activity in patients with fibrosing lung diseases

K. Kuwano, T. Maeyama, N. Hagimoto, 2002, Respirology.

Amphiregulin attenuates bleomycin-induced pneumopathy in mice.

K. Kuwano, T. Maeyama, N. Hamada, 2010, American journal of physiology. Lung cellular and molecular physiology.

Transcriptional Events during the Recovery from MRSA Lung Infection: A Mouse Pneumonia Model

R. Wunderink, G. Feng, J. Garcia, 2013, PloS one.

Attenuation of pulmonary hypertension, but not emphysematous change, by breeding emphysema model mice at sea level.

I. Inoshima, Y. Nakanishi, M. Fujita, 2008, Cytokine.

Clinical efficacy and safety of cefepime in febrile neutropenic patients with lung cancer

I. Inoshima, Y. Nakanishi, M. Kawasaki, 2010, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Biphasic effects of free radical scavengers against bleomycin-induced pulmonary fibrosis.

M. Yoshimi, I. Inoshima, Y. Nakanishi, 2008, Pulmonary pharmacology & therapeutics.

The role of collagenases in experimental pulmonary fibrosis.

K. Kuwano, I. Inoshima, Y. Nakanishi, 2008, Pulmonary pharmacology & therapeutics.

TNF receptor 1 and 2 contribute in different ways to resistance to Legionella pneumophila-induced mortality in mice.

I. Inoshima, Y. Nakanishi, M. Fujita, 2008, Cytokine.

A Staphylococcus aureus Pore-Forming Toxin Subverts the Activity of ADAM10 to Cause Lethal Infection

I. Inoshima, J. B. Wardenburg, K. Frank, 2011, Nature Medicine.

Tubulointerstitial nephritis and IgA nephropathy in a patient with advanced lung cancer treated with long-term gefitinib

I. Inoshima, K. Fujisaki, H. Hirakata, 2008, Clinical and Experimental Nephrology.

TGF-beta 1 as an enhancer of Fas-mediated apoptosis of lung epithelial cells.

K. Kuwano, T. Maeyama, N. Hagimoto, 2002, Journal of immunology.

Doxycycline Attenuated Pulmonary Fibrosis Induced by Bleomycin in Mice

K. Kuwano, I. Inoshima, Y. Nakanishi, 2006, Antimicrobial Agents and Chemotherapy.

Serum CC-10 in Inflammatory Lung Diseases

K. Kuwano, T. Maeyama, I. Inoshima, 2004, Respiration.

Doxycycline attenuated lung injury by its biological effect apart from its antimicrobial function.

I. Inoshima, Y. Nakanishi, M. Fujita, 2007, Pulmonary pharmacology & therapeutics.

, Ichiro Fibrosis Induced by Bleomycin in Mice Doxycycline Attenuated Pulmonary

K. Kuwano, I. Inoshima, Y. Nakanishi, 2006 .

Attenuation of bleomycin-induced pneumopathy in mice by a caspase inhibitor.

K. Kuwano, T. Maeyama, N. Hagimoto, 2001, American journal of physiology. Lung cellular and molecular physiology.

Linezolid Exerts Greater Bacterial Clearance but No Modification of Host Lung Gene Expression Profiling: A Mouse MRSA Pneumonia Model

R. Wunderink, G. Feng, I. Inoshima, 2013, PloS one.

Protection against the Extravasation of Anticancer Drugs by Standardization of the Management System

I. Inoshima, Y. Nakanishi, R. Oishi, 2008 .

Successful treatment of refractory chronic necrotizing pulmonary aspergillosis with micafungin

I. Inoshima, Y. Nakanishi, M. Fujita, 2007, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

COVID-19 mRNA Vaccine-induced Pneumonitis

I. Inoshima, Y. Hirasawa, H. Kamiya, 2021, Internal medicine.

Gorham's disease of the chest wall: CT and MR characteristics.

H. Honda, I. Inoshima, H. Yabuuchi, 2005, Journal of thoracic imaging.